ClinicalTrials.gg
Drug

Mitomycin clinical trials

Also written Mutamycin and Mitosol.

studies test it
134
open now
24
in phase 3
33
first study started
1992

How each study uses Mitomycin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Mitomycin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
24 Aug 1981 · MUTAMYCIN · ANDA 062336 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Mitomycin C
64
Mitomycin
30
Mitomycin-C
11
MMC
5
Mitomycin C (MMC)
5

Brand

Mutamycin
6
Mitosol
3
Jelmyto
1
Mitocin-C
1

Development codes

NSC-26980
1

In one entry with another drug

Given together, or one or the other

UGN-102
4
UGN-101
2

Studies by the year they started

131 studies that test it; most in 2014 (10); 1 more planned to start later

Studies that test Mitomycin, by start year
YearStudies
19921
19942
19962
19972
19982
19994
20013
20021
20033
20043
20054
20065
20073
20082
20097
20101
20112
20125
20134
201410
20158
20166
20177
20183
20194
20206
20215
20224
20236
20244
20254
20268

By phase

A phase 1/2 study counts in both.

Early Phase 1
4
Phase 1
18
Phase 2
66
Phase 3
33
Phase 4
13
No phase
11

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 10 · Other 124

UroGen Pharma Ltd. (7) · Shahid Beheshti University of Medical Sciences (5) · National Cancer Institute (NCI) (4) · Memorial Sloan Kettering Cancer Center (3) · Fox Chase Cancer Center (3) · Radiation Therapy Oncology Group (3) · M.D. Anderson Cancer Center (3) · University of California, San Francisco (3)

Often tested with

Tested in the same studies.

Fluorouracil (25) · Cisplatin (22) · Gemcitabine (13) · Capecitabine (9) · Doxorubicin (6) · Leucovorin (4) · Docetaxel (4) · SR Mitomycin Intravesical Solution (4)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 6 phase 3 studies under way

Mitomycin is the comparator. A study of two new drugs counts under both.

  • 1Gemcitabine-Releasing Intravesical System · Janssen Research & Development, LLC · next primary completion Nov 2030
  • 1Enfortumab vedotin · Astellas Pharma Global Development, Inc. · next primary completion Mar 2030
  • 1Pembrolizumab · Astellas Pharma Global Development, Inc. · next primary completion Mar 2030
  • 1Efserakefusp alfa · Suzhou Suncadia Biopharmaceuticals Co., Ltd. · next primary completion Jun 2030
  • 1Sintilimab · Cancer Institute and Hospital, Chinese Academy of Medical Sciences · next primary completion Mar 2029
Reaching primary completion within a year · 9, 2 in phase 3

Studies that test Mitomycin, phase 3 first.

Studies

Open first, then newest update. How each study uses Mitomycin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 134

See all 134 studies that test Mitomycin →

Given beside what is tested · 16 — Mitomycin is usual care or a partner of the new treatment
As the comparator · 24 — what is tested is compared with Mitomycin

Showing 20 of 24.

Codes

What other systems call Mitomycin · ClinicalTrials.gg INT008539

  • MeSH (NLM) D016685MitomycinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 50SG953SK6MITOMYCINConfirmed FDA, NLM, Wikidata
  • RxNorm 632Confirmed FDA, Wikidata
  • Wikidata Q19856779mitomycinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1820MitomycinOne source FDA
  • DrugBank DB00305One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.